USANA Health Sciences, Inc. (USNA) Insider Walter Noot Sells 3,075 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Walter Noot sold 3,075 shares of the firm’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $77.00, for a total transaction of $236,775.00. Following the transaction, the insider now owns 3,075 shares of the company’s stock, valued at $236,775. The transaction was disclosed in a document filed with the SEC, which is available at this link.

USANA Health Sciences, Inc. (USNA) traded up $0.75 during trading hours on Friday, reaching $77.60. 35,276 shares of the company’s stock traded hands, compared to its average volume of 91,674. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $79.00. The stock has a market cap of $1,817.44, a P/E ratio of 30.72 and a beta of 0.99.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, February 6th. The company reported $1.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.00 by $0.11. USANA Health Sciences had a net margin of 5.97% and a return on equity of 27.02%. The firm had revenue of $273.11 million during the quarter, compared to the consensus estimate of $258.67 million. During the same period last year, the firm posted $0.87 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. sell-side analysts forecast that USANA Health Sciences, Inc. will post 4.25 EPS for the current fiscal year.

Several equities analysts have weighed in on USNA shares. Pivotal Research raised their target price on shares of USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, October 25th. TheStreet downgraded shares of USANA Health Sciences from a “b+” rating to a “c+” rating in a report on Tuesday, February 6th. BidaskClub upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Thursday, October 26th. Finally, Sidoti downgraded shares of USANA Health Sciences from a “buy” rating to a “neutral” rating in a report on Wednesday, January 24th.

Several hedge funds and other institutional investors have recently modified their holdings of USNA. US Bancorp DE grew its holdings in shares of USANA Health Sciences by 730.1% during the fourth quarter. US Bancorp DE now owns 2,374 shares of the company’s stock worth $176,000 after buying an additional 2,088 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of USANA Health Sciences during the third quarter worth about $189,000. Creative Planning purchased a new stake in shares of USANA Health Sciences during the fourth quarter worth about $219,000. Hikari Power Ltd purchased a new stake in shares of USANA Health Sciences during the fourth quarter worth about $255,000. Finally, Stone Ridge Asset Management LLC purchased a new stake in shares of USANA Health Sciences during the fourth quarter worth about $265,000. Institutional investors and hedge funds own 44.67% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/16/usana-health-sciences-inc-usna-insider-walter-noot-sells-3075-shares-of-stock.html.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply